COVID-19 (coronavirus): resources for the oral and dental care team

Coronavirus disease (COVID-19) is caused by a new strain of Coronavirus (SARS-CoV-2) discovered in 2019, and not previously identified in humans. Common symptoms include fever, cough, and shortness of breath. On 11 March 2020, the World Health Organization (WHO) announced the current COVID-19 outbreak as a pandemic.

For authoritative information about the science underpinning the epidemic, see the UK Research and Innovation Coronavirus resource.

Cochrane Oral Health are collecting information and guidance from international professional dental bodies. At this time, it is more important than ever to work together and the Global Evidence Ecosystem for Oral Health (GEEOH) will continue to do this.

We will publish links on this page as they become available. If you would like us to link to a resource that is not currently on our list, please contact us.

Guidance for the oral and dental care team from our Global Alliance and GEEOH partners:

Cochrane Oral Health reviews

Cochrane Oral Health have produced the following reviews in conjunction with Cochrane ENT:

Read a summary of the findings here.

Other guidance for the oral and dental care team:

Cochrane evidence

1. Cochrane resources and news: Cochrane has an extensive collection of resources related to COVID-19 and these are available hereCochrane Clinical Answers, summaries of the evidence produced for clinicians, have been developed. Find them here.

2. Cochrane Special Collections relating to coronavirus have been developed:

3. Cochrane COVID Rapid Reviews. The Cochrane COVID Review Bank includes:

  • Review titles that Cochrane has committed to supporting and keeping up to date (see priorities diagram).
  • Questions or topics that fall within the priority areas where high-quality submissions will be considered.
  • COVID Reviews underway within Cochrane Review Groups that are priorities within a given clinical area.

Details of how questions were collected and prioritized can be found on the Prioritization page.

4. COVID-19 Consumer rapid response group. Cochrane are recruiting consumers to be a part of a COVID-19 consumer rapid response group. Cochrane are particularly looking for healthcare consumers who have experience of helping with Cochrane or other systematic reviews, and have experience of COVID-19 either as a patient, an informal carer or as someone at high risk of catching the disease. Find out more here

In December 2020, a supplement to the Cochrane Library was published: Collaborating in response to COVID-19: editorial and methods initiatives across Cochrane. It pulls together information on Cochrane's various projects and initiatives to combat COVID-19. Read an accompanying editorial here.

In November 2020, an editorial was published in the Cochrane Library: Policymakers must act on incomplete evidence in responding to COVID-19.

Relevant Cochrane reviews published so far:

General guidance on COVID-19:

COVID-19 trials in-progress and data from trials

Cochrane has launched a COVID-19 trial register to support rapid evidence synthesis, find it here.

For a register of COVID-19-related trials that are in-progress and may – or may not – have yet published results (links are included when results are available) please see Covid-19 TrialsTracker.

Cochrane's partner Vivli is collecting and sharing data from COVID-19-related clinical trials (published data and individual patient data from published and unpublished trials); find out more here.